These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14662887)

  • 61. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH; Ajaz M; Lokshin A; Lee YJ
    Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes.
    Dickensheets HL; Donnelly RP
    J Immunol; 1997 Dec; 159(12):6226-33. PubMed ID: 9550426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
    Franchimont N; Lambert C; Huynen P; Ribbens C; Relic B; Chariot A; Bours V; Piette J; Merville MP; Malaise M
    Arthritis Rheum; 2005 Jan; 52(1):84-93. PubMed ID: 15641051
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulation of interleukin-1beta and interleukin-1beta inhibitor release by human airway epithelial cells.
    Yang Y; Bin W; Aksoy MO; Kelsen SG
    Eur Respir J; 2004 Sep; 24(3):360-6. PubMed ID: 15358691
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma.
    Zhang XD; Franco A; Myers K; Gray C; Nguyen T; Hersey P
    Cancer Res; 1999 Jun; 59(11):2747-53. PubMed ID: 10364001
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations.
    Dentener MA; Creutzberg EC; Schols AM; Mantovani A; van't Veer C; Buurman WA; Wouters EF
    Thorax; 2001 Sep; 56(9):721-6. PubMed ID: 11514694
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum cytokine receptors in ankylosing spondylitis: relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms.
    Haroon N; Tsui FW; Chiu B; Tsui HW; Inman RD
    J Rheumatol; 2010 Sep; 37(9):1907-10. PubMed ID: 20595269
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Concentration of interleukin-18, interleukin-1beta, soluble receptor for interleukin-1 (sIL-1RII) and C-reactive protein in patients with neuroborreliosis].
    Pietruczuk A; Swierzbińska R; Pietruczuk M; Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
    Neurol Neurochir Pol; 2005; 39(1):33-9. PubMed ID: 15735988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Shedding of tumour necrosis factor receptors from purified villous term trophoblasts and cytotrophoblastic BeWo cells.
    Knöfler M; Stenzel M; Husslein P
    Hum Reprod; 1998 Aug; 13(8):2308-16. PubMed ID: 9756317
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.
    Vannier E; Kaser A; Atkins MB; Fantuzzi G; Dinarello CA; Mier JW; Tilg H
    Eur Cytokine Netw; 1999 Mar; 10(1):37-42. PubMed ID: 10210771
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interleukin-1beta (IL-1beta)-induced modulation of the hypothalamic IL-1beta system, tumor necrosis factor-alpha, and transforming growth factor-beta1 mRNAs in obese (fa/fa) and lean (Fa/Fa) Zucker rats: implications to IL-1beta feedback systems and cytokine-cytokine interactions.
    Plata-Salamán CR; Ilyin SE
    J Neurosci Res; 1997 Sep; 49(5):541-50. PubMed ID: 9302075
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
    J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA; Grosen EA; Ioli GR; Van Eden ME; Brightbill HD; Gatanaga M; DiSaia PJ; Granger GA; Gatanaga T
    Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diosgenin, an Activator of 1,25D3-MARRS Receptor/ERp57, Attenuates the Effects of TNF-α by Causing ADAM10-Dependent Ectodomain Shedding of TNF Receptor 1.
    Yang WS; Moon SY; Lee MJ; Lee EK; Park SK
    Cell Physiol Biochem; 2017; 43(6):2434-2445. PubMed ID: 29073626
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance.
    Colagiovanni DB; Shopp GM
    Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):397-419. PubMed ID: 8872492
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mechanisms involved in the processing of the p55 and the p75 tumor necrosis factor (TNF) receptors to soluble receptor forms.
    Björnberg F; Lantz M; Olsson I; Gullberg U
    Lymphokine Cytokine Res; 1994 Jun; 13(3):203-11. PubMed ID: 7948429
    [TBL] [Abstract][Full Text] [Related]  

  • 77. TNF-alpha/TNFRI in primary and immortalized first trimester cytotrophoblasts.
    Knöfler M; Mösl B; Bauer S; Griesinger G; Husslein P
    Placenta; 2000; 21(5-6):525-35. PubMed ID: 10940203
    [TBL] [Abstract][Full Text] [Related]  

  • 78. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.
    Reddy J; Chastagner P; Fiette L; Liu X; Thèze J
    Int Immunol; 2001 Feb; 13(2):135-47. PubMed ID: 11157847
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin-1 beta suppresses apoptosis in CD34 positive bone marrow cells through activation of the type I IL-1 receptor.
    Rodriguez C; Lacasse C; Hoang T
    J Cell Physiol; 1996 Feb; 166(2):387-96. PubMed ID: 8591999
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.
    Meng RD; McDonald ER; Sheikh MS; Fornace AJ; El-Deiry WS
    Mol Ther; 2000 Feb; 1(2):130-44. PubMed ID: 10933923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.